We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

125 hedge funds and large institutions have $276M invested in Cytokinetics in 2015 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more call options, than puts

Call options by funds: $5.19M | Put options by funds: $2.02M

143% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 14

89% more capital invested

Capital invested by funds: $146M → $276M (+$130M)

19% more funds holding

Funds holding: 105 → 125 (+20)

17% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 36

Holders
125
Holders Change
+20
Holders Change %
+19.05%
% of All Funds
3.28%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
34
Increased
42
Reduced
36
Closed
14
Calls
$5.19M
Puts
$2.02M
Net Calls
+$3.17M
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$13.9M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$10.6M
3
BI
BVF Inc
California
+$7.98M
4
RFC
Russell Frank Company
Washington
+$4.4M
5
EI
EAM Investors
California
+$4.11M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$7.14M
2
Millennium Management
Millennium Management
New York
-$4.14M
3
OAM
Oxford Asset Management
United Kingdom
-$2.49M
4
SFM
Sphera Funds Management
Israel
-$2.49M
5
TC
TFS Capital
Pennsylvania
-$2.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$2.69M +$2.52M +256,665 New
IIM
27
Ironwood Investment Management
Massachusetts
$2.62M -$894K -91,111 -27%
MCM
28
Matarin Capital Management
New York
$2.51M +$779K +79,396 +49%
TCIM
29
TIAA CREF Investment Management
New York
$2.51M -$51.5K -5,254 -2%
Balyasny Asset Management
30
Balyasny Asset Management
Illinois
$2.43M +$2.28M +232,430 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.41M +$940K +95,823 +71%
PAM
32
Panagora Asset Management
Massachusetts
$2.16M -$130K -13,276 -6%
Ameriprise
33
Ameriprise
Minnesota
$2.03M +$1.9M +194,179 New
PP
34
PDT Partners
New York
$1.79M -$243K -24,800 -13%
SGAM
35
Smith Group Asset Management
Texas
$1.63M -$209K -21,340 -12%
OAM
36
Oxford Asset Management
United Kingdom
$1.55M -$2.49M -254,296 -63%
SIM
37
Spark Investment Management
New York
$1.5M +$639K +65,100 +83%
BIM
38
BlackRock Investment Management
Delaware
$1.33M +$11.4K +1,160 +0.9%
FIM
39
Freedom Investment Management
Connecticut
$1.32M +$1.08M +110,508 +693%
PAI
40
Palo Alto Investors
California
$1.29M – – –
BA
41
BlackRock Advisors
Delaware
$1.28M -$624K -63,655 -34%
Morgan Stanley
42
Morgan Stanley
New York
$1.27M -$7.14M -727,832 -86%
GCP
43
GSA Capital Partners
United Kingdom
$1.23M +$974K +99,287 +533%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.23M +$342K +34,900 +42%
CAM
45
ClariVest Asset Management
California
$1.06M +$991K +100,991 New
HVC
46
Healthcare Value Capital
New Jersey
$1.05M – – –
Asset Management One
47
Asset Management One
Japan
$922K +$864K +88,124 New
ARTA
48
A.R.T. Advisors
New York
$886K +$434K +44,246 +109%
AI
49
Analytic Investors
California
$877K +$822K +83,837 New
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
$873K -$289K -29,500 -26%
1
2
3 4 5

CYTK Hedge Fund Activity: Q4 2015 in Review

125 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2015, worth a combined $276M — up 89% from $146M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new CYTK positions and 14 closed out — a net gain of 20 holders — while 42 added to existing stakes and 36 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $13.9M. The largest seller was Morgan Stanley, cutting an estimated $7.14M.

  • 125 institutional investors held Cytokinetics (CYTK) as of Q4 2015, up from 105 in Q3 2015.
  • Funds reported $276M of Cytokinetics stock for Q4 2015, up 89% quarter-over-quarter.
  • 34 funds opened new Cytokinetics positions in Q4 2015 and 14 closed out, a net change of +20 holders.
  • The largest Cytokinetics buyer in Q4 2015 was EcoR1 Capital, an estimated $13.9M added.
  • The largest Cytokinetics seller in Q4 2015 was Morgan Stanley, an estimated $7.14M sold.

Based on aggregated 13F filings for Q4 2015.